Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Greipp

Showing results (141-150 of 178) with videos related to

Pageof 18
Sort By:
Leukemia|August 2, 2001
Thalidomide for previously untreated indolent or smoldering multiple myelomaS V Rajkumar, A Dispenzieri, R Fonseca, et al.
American Journal of Clinical Pathology|March 1, 1989
Rapid S-phase determination of non-Hodgkin's lymphomas with the use of an immunofluorescence bromodeoxyuridine labeling index procedureT E Witzig, N J Gonchoroff, P R Greipp, et al.
American Journal of Hematology|January 5, 2002
Methods for estimation of bone marrow plasma cell involvement in myeloma: predictive value for response and survival in patients undergoing autologous stem cell transplantationS V Rajkumar, R Fonseca, A Dispenzieri, et al.
Blood|April 18, 1998
Plasmablastic morphology--an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory GroupP R Greipp, T Leong, J M Bennett, et al.
Bone Marrow Transplantation|July 22, 1999
Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myelomaS V Rajkumar, R Fonseca, M Q Lacy, et al.
Blood Cancer Journal|September 3, 2016
Outcome with lenalidomide plus dexamethasone followed by early autologous stem cell transplantation in patients with newly diagnosed multiple myeloma on the ECOG-ACRIN E4A03 randomized clinical trial: long-term follow-upN Biran, S Jacobus, D H Vesole, et al.
Leukemia|June 22, 2001
Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomyR Fonseca, M M Oken, D Harrington, et al.
Journal of the American College of Cardiology|October 1, 1985
Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survivalL Cueto-Garcia, G S Reeder, R A Kyle, et al.
The American Journal of the Medical Sciences|March 1, 1995
Refractory and relapsing multiple myeloma treated by blood stem cell transplantationM A Gertz, A A Pineda, M G Chen, et al.
Bone Marrow Transplantation|July 22, 1999
Autologous stem cell transplantation for relapsed and primary refractory myelomaS V Rajkumar, R Fonseca, M Q Lacy, et al.
Pageof 18

Showing results (141-150 of 178) with videos related to

Sort By:
Pageof 18
Leukemia|August 2, 2001
Thalidomide for previously untreated indolent or smoldering multiple myelomaS V Rajkumar, A Dispenzieri, R Fonseca, et al.
American Journal of Clinical Pathology|March 1, 1989
Rapid S-phase determination of non-Hodgkin's lymphomas with the use of an immunofluorescence bromodeoxyuridine labeling index procedureT E Witzig, N J Gonchoroff, P R Greipp, et al.
American Journal of Hematology|January 5, 2002
Methods for estimation of bone marrow plasma cell involvement in myeloma: predictive value for response and survival in patients undergoing autologous stem cell transplantationS V Rajkumar, R Fonseca, A Dispenzieri, et al.
Blood|April 18, 1998
Plasmablastic morphology--an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory GroupP R Greipp, T Leong, J M Bennett, et al.
Bone Marrow Transplantation|July 22, 1999
Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myelomaS V Rajkumar, R Fonseca, M Q Lacy, et al.
Blood Cancer Journal|September 3, 2016
Outcome with lenalidomide plus dexamethasone followed by early autologous stem cell transplantation in patients with newly diagnosed multiple myeloma on the ECOG-ACRIN E4A03 randomized clinical trial: long-term follow-upN Biran, S Jacobus, D H Vesole, et al.
Leukemia|June 22, 2001
Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomyR Fonseca, M M Oken, D Harrington, et al.
Journal of the American College of Cardiology|October 1, 1985
Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survivalL Cueto-Garcia, G S Reeder, R A Kyle, et al.
The American Journal of the Medical Sciences|March 1, 1995
Refractory and relapsing multiple myeloma treated by blood stem cell transplantationM A Gertz, A A Pineda, M G Chen, et al.
Bone Marrow Transplantation|July 22, 1999
Autologous stem cell transplantation for relapsed and primary refractory myelomaS V Rajkumar, R Fonseca, M Q Lacy, et al.
Pageof 18